Credit facility composed of two secured term loans bearing interest at 7.5%. Will be used to retire current secured debt, which currently bears an average rate of 10%. All currency is presented in USD.

VANCOUVER, BC, July 8, 2022 /CNW/ – Vext Science, Inc. (“Vext” or the “Company”) (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that it has entered into an agreement with a California-based lender for a $22.2 million credit facility (the “Credit Facility”), which will be used to refinance current secured debt, and working capital for potential acquisitions, capital expenditures and general and administrative expenses.

Eric Offenberger, CEO of Vext stated, “This credit facility both lowers Vext’s cost of capital, and gives us additional flexibility as we continue to execute our growth plans in Arizona and Ohio. The next 12 months are expected to be a period of growth for Vext. With a solid balance sheet, ongoing free cash flow, and access to relatively low cost, non-dilutive capital, we are in a position of strength to continue generating growth and profitability for shareholders.”

Terms of Credit Facility

The Credit Facility is comprised of two term loans. The first, is a $17.185 million 20-year first lien secured term loan, bearing interest of WSJ Prime + 2.75%, with a floor price of 6.25%. The second, is a $5 million five-year second lien secured term loan, bearing interest at WSJ Prime + 2.75%, with a floor price of 6.25%.

Canaccord Genuity acted as a financial adviser to Vext in connection with the Credit Facility.

For more details, visit Vext’s investor website or contact the IR team at [email protected].

About Vext Science, Inc.

Vext Science, Inc. is a US-based Cannabis THC and Hemp cannabinoid products company manufacturing THC cartridges, concentrates, edibles and accessories under the Vapen Brand, and Hemp based products under the Pure Touch Botanicals brand as well as the Vapen CBD brand. Based in Arizona, Vext Science, Inc. has one of the leading THC concentrates, edibles, and distillate cartridge brands sold in most of the state’s 100+ dispensaries. Herbal Wellness Center is one of Arizona’s leading dispensaries and we execute all aspects of the cultivation, extraction, edibles infusion and manufacturing processes which insures a product of the highest quality and purity. Product quality and purity are core to our marketing strategy. Vext Science, Inc. is executing its business growth by leveraging experience and expertise in extractions, product manufacturing, and marketing to expand in the U.S. through revenue and profit-sharing joint venture partnerships. For more information visit our website at www.VextScience.com or connect with us on LinkedIn and Twitter.

For more details on the Vapen brand:

Vapen website: VapenBrands.com

Instagram: @vapen

Facebook: @vapenbrands

COVID-19 Risk Factor

Vext may be impacted by business interruptions resulting from pandemics and public health emergencies, including those related to COVID-19. An outbreak of infectious disease, a pandemic, or a similar public health threat, such as the recent outbreak of COVID-19, or a fear of any of the foregoing, could adversely impact Vext by causing operating, manufacturing, supply chain, and project development delays and disruptions, labor shortages, travel, and shipping disruption and shutdowns (including as a result of government regulation and prevention measures). It is unknown whether and how Vext may be affected if such a pandemic persists for an extended period of time, including as a result of the waiver of regulatory requirements or the implementation of emergency regulations to which Vext is subject. Although Vext has been deemed essential and/or has been permitted to continue operating its facilities in the states in which it operates during the pendency of the COVID-19 pandemic, there is no assurance that the Company’s operations will continue to be deemed essential and/or will continue to be permitted to operate. Vext may incur expenses or delays relating to such events outside of its control, which could have a material adverse impact on its business, operating results, financial condition and the trading price of the Company’s Common Shares.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward- looking statements.

Forward-looking statements may include, without limitation, statements related COVID-19, to future developments, the expected use of the Credit Facility and the business and operations of Vext.

Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward- looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Eric Offenberger
Chief Executive Officer
844-211-3725

SOURCE VEXT Science, Inc

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

JACKSONVILLE, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) — LFTD Partners Inc., formerly known as Acquired Sales Corp. (OTCQX: AQSP) (www.AcquiredSalesCorp.com), today announced that during the second quarter of 2021 it achieved quarter-over-quarter growth in revenue of 99%, from $3,353,270 to $6,695,144, quarter-over-quarter growth in net income of 158%, from $618,359 to $1,596,154, and quarter-over-quarter growth in basic earnings per share of 75%, from $0.08 to $0.14, driven by the growth of its wholly-owned subsidiary Lifted Made (www.LiftedMade.com), maker of the award-winning Urb Finest Flowers brand of hemp-derived delta-8-THC, delta-9-THC, delta-10-THC and other emerging cannabinoid products.

Nicholas S. Warrender, Vice Chairman and COO of AQSP, and founder and CEO of Lifted Made, said: “The second quarter is a solid reflection of our foundational work over the past six months. Having moved into our new facility in Kenosha in March, we have automated production and increased capacity to meet growing demand while expanding vendor relations to reduce costs, a great challenge in this business climate. This has led to increased gross margins, allowing us to become even more competitive in the marketplace. We have relentlessly continued to expand our distribution network throughout the country. Our staff continues to expand, with an aggressive focus on revenue growth through very exciting ‘first to market’ products. I believe that between the organic growth of Lifted Made, and our planned merger with Savage Enterprises, we are well on our way toward achieving our goal of creating the most profitable and largest public company in the space.”

William C. “Jake” Jacobs, President and CFO of both AQSP and Lifted Made, said: “For the fourth straight quarter, we have proven that we are one of the few companies in the cannabis industry that can grow our revenues and profits at an extremely fast pace. Lifted currently has over $3.3 million cash in the bank. We are excited to be partnering with Savage Enterprises, a group of like-minded people, and we are looking forward to bringing other great entrepreneurs into AQSP, in a decentralized environment that doesn’t disrupt the entrepreneurs or the mojo of their companies.”

Christopher G. Wheeler, CEO of award-winning e-liquid and cannabinoid-infused products maker Savage Enterprises (www.SavageEnterprises.com) (“Savage”), Irvine, California, which has signed a letter of intent to merge into AQSP, the closing of which is subject to a number of contingencies, said, “We are super excited for the partnership with Lifted Made and AQSP. Savage Enterprises continues to grow, and is on an insane trajectory, having unaudited sales of $5.3 million in the first quarter of 2021, over $10 million in sales in the second quarter of 2021, and more than $5 million in sales in July of 2021, bringing our unaudited year to date totals to over $20 million. Our goal is to accelerate the growth and profitability of both Savage and Lifted Made.”

Matt Winters, CFO of Savage, commented, “The Savage team and I are very excited to be a part of such an explosively growing company. Savage has broken sales records month after month for the last two quarters. And, Lifted’s numbers speak for themselves. Both companies have had a phenomenal first half of the year, and we plan to finish strong. I feel that the synergy between both companies will bring both Savage and Lifted to new heights. I anticipate that we will hit sales figures in quarter four of this year that I previously thought we wouldn’t see until late next year. With both Lifted and Savage’s combined ability to market, promote, manufacture, and sell high quality hemp-derived cannabis products, I feel that we are going to continue to have this explosive growth, with a plethora of new products coming in the pipe. We are very excited and continue to work diligently on our audits and other due diligence items necessary for the closing of our merger with AQSP, while still delivering the best, highest quality, affordable, and beautifully designed products to market. Stay tuned!”

About Lifted Made and LFTD Partners Inc., Formerly Known as Acquired Sales Corp.

Lifted Made was founded in 2014 by CEO Nicholas S. Warrender. Lifted Made is a leading manufacturer of hemp and hemp-derived products. Urb Finest Flowers is Lifted Made’s flagship, award-winning brand. In February 2020, Lifted Made became a wholly-owned subsidiary of publicly traded LTFD Partners Inc., formerly known as Acquired Sales Corp. (OTCQX ticker symbol AQSP). Lifted Made’s products can be purchased online at www.LiftedMade.com.

LFTD Partners Inc., formerly known as Acquired Sales Corp. (OTCQX ticker symbol AQSP) is focused upon acquiring rapidly growing companies that manufacture and sell branded hemp-derived cannabinoid products (e.g. delta-8-THC, delta-10-THC, THCV, THCO, CBDA, CBC, CBG, CBN, CBD), e-liquid, disposable nicotine vapes, kratom and kava products. In February, 2020, AQSP acquired 100% of Warrender Enterprise Inc. d/b/a Lifted Made (formerly d/b/a Lifted Liquids) (www.LiftedMade.com), now located in Kenosha, Wisconsin. Lifted Made has a 50% membership interest in SmplyLifted LLC, which sells tobacco-free nicotine pouches under the brand name FR3SH (www.GETFR3SH.com). AQSP also owns 4.99% of CBD-infused beverage and products maker Ablis Holding Company (www.AblisBev.com), and of craft distillers Bendistillery Inc. d/b/a Crater Lake Spirits (www.CraterLakeSpirits.com) and Bend Spirits, Inc. (www.Bendistillery.com), all located in Bend, Oregon. AQSP has also signed a letter of intent to acquire delta-8-THC and CBD industry leader Savage Enterprises, and to enter the California marijuana industry by purchasing Premier Greens LLC and MKRC Holdings, LLC, the closing of which transactions are subject to a number of contingencies.

Please read AQSP’s filings with the U.S. SEC which fully describe our business and the Risk Factors associated therewith. Learn more by subscribing to our newsletters at www.LiftedMade.com and www.AcquiredSalesCorp.com.

Cautionary Note Regarding Forward-Looking Statements Certain statements in this document are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such information includes the growth and profitability strategies, and future products and plans of Lifted Made, SmplyLifted LLC, LFTD Partners Inc., formerly known as Acquired Sales Corp., Savage Enterprises and related entities. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to the actual results of these companies’ operations or the performance or achievements of these companies differing materially from those expressed or implied by the forward-looking statements. These companies undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain other factors, including the risk factors set forth in AQSP’s filings with the Securities and Exchange Commission.

CONTACTS:

Lifted Made
Attn: Nicholas S. Warrender, CEO
Phone: 224-577-8148
Email: [email protected]
Website: www.LiftedMade.com

LFTD Partners Inc., Formerly Known as Acquired Sales Corp.
Attn: William C. “Jake” Jacobs, President and CFO
Phone: 847-400-7660
Email: [email protected]
Website: www.AcquiredSalesCorp.com

Savage Enterprises
Attn: Brittany Warner
Phone: 714-612-1091
Email: [email protected]
Website: www.SavageEnterprises.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

VANCOUVER, BC, June 25, 2021 /CNW/ – Vext Science, Inc. (“Vext” or the “Company”) (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced the closing of its purchase of a vacant 72,000 square foot industrial located in the city of Eloy, Arizona (the “Eloy Facility”). As previously announced, Vext has received approval to build and operate a state-of-the-art medical cannabis cultivation operation at the Eloy Facility. The Company expects to build the facility out to approximately 34,000 square feet under canopy within nine months of closing. The Eloy Facility also includes ample land for future expansion. All currency references used in this news release are in U.S. currency unless otherwise noted.

“Once the Eloy Facility is operational, Vext will have total indoor capacity of ~58,000 square feet under canopy and 10 acres of outdoor capacity, to support further growth in Arizona,” said Eric Offenberger, CEO of Vext. “The Eloy Facility will provide additional high quality flower to support the ongoing growth of our award-winning Vapen brand, and in our operated dispensaries, while enabling us to accretively grow our retail footprint in the state over time. Locations with suitable scale and proximity to major population centers are likely to get more difficult to find in the coming years, and we expect ownership of our cultivation footprint to be an enduring competitive advantage for Vext.”

Vext paid $4.3 million in cash for outright ownership of the Eloy Facility, which is currently vacant.

For more details, visit VEXT’s investor website or contact the IR team at [email protected].

About VEXT Science, Inc.

Vext Science, Inc. is a US-based Cannabis THC and Hemp cannabinoid products company manufacturing THC cartridges, concentrates, edibles and accessories under the Vapen Brand, and Hemp based products under the Pure Touch Botanicals brand as well as the Vapen CBD brand. Based in Arizona, Vext Science, Inc. has one of the leading THC concentrates, edibles, and distillate cartridge brands sold in most of the state’s 100+ dispensaries. Herbal Wellness Center is one of Arizona’s leading dispensaries and we execute all aspects of the cultivation, extraction, edibles infusion and manufacturing processes which insures a product of the highest quality and purity. Product quality and purity are core to our marketing strategy. Vext Science, Inc. is executing its business growth by leveraging experience and expertise in extractions, product manufacturing, and marketing to expand in the U.S. through revenue and profit-sharing joint venture partnerships. For more information visit our website at www.VextScience.com.

For more details on the Vapen brand:
Vapen website: VapenBrands.com 
Instagram: @vapen 
Facebook: @vapenclear

COVID-19 Risk Factor

VEXT may be impacted by business interruptions resulting from pandemics and public health emergencies, including those related to COVID-19. An outbreak of infectious disease, a pandemic, or a similar public health threat, such as the recent outbreak of COVID-19, or a fear of any of the foregoing, could adversely impact VEXT by causing operating, manufacturing, supply chain, and project development delays and disruptions, labor shortages, travel, and shipping disruption and shutdowns (including as a result of government regulation and prevention measures). It is unknown whether and how VEXT may be affected if such a pandemic persists for an extended period of time, including as a result of the waiver of regulatory requirements or the implementation of emergency regulations to which VEXT is subject. Although VEXT has been deemed essential and/or has been permitted to continue operating its facilities in the states in which it operates during the pendency of the COVID-19 pandemic, there is no assurance that the Company’s operations will continue to be deemed essential and/or will continue to be permitted to operate. VEXT may incur expenses or delays relating to such events outside of its control, which could have a material adverse impact on its business, operating results, financial condition and the trading price of the Company’s Common Shares.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in VEXT’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should, on track” and similar expressions, are forward- looking statements.

Forward-looking statements may include, without limitation, statements related COVID-19, to future developments and the business and operations of VEXT, the Company’s market position in the State of Arizona, the size and build-out timeline for the Eloy Facility, and the Company’s financial results, and of which are subject to the risk factors contained in Vext’s continuous disclosure filed on SEDAR.

Although VEXT has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward- looking statements in this news release are made as of the date of this release. VEXT disclaims any intention or obligation to update or revise such information, except as required by applicable law, and VEXT does not assume any liability for disclosure relating to any other company mentioned herein.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Eric Offenberger
Chief Executive Officer
844-211-3725

SOURCE VEXT Science, Inc.

For further information: Jonathan Ross, VEXT Investor Relations, [email protected], 416-283-0178

Related Links

https://vextscience.com/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.